Edition:
United Kingdom

NxStage Medical Inc (NXTM.OQ)

NXTM.OQ on NASDAQ Stock Exchange Global Select Market

26.02USD
15 Dec 2017
Change (% chg)

$0.19 (+0.74%)
Prev Close
$25.83
Open
$25.70
Day's High
$26.10
Day's Low
$25.70
Volume
414,513
Avg. Vol
225,826
52-wk High
$30.80
52-wk Low
$20.47

Latest Key Developments (Source: Significant Developments)

NXSTAGE SAYS STOCKHOLDER APPROVE MERGER WITH FRESENIUS MEDICAL CARE
Friday, 27 Oct 2017 

Oct 27 (Reuters) - NxStage Medical ::NXSTAGE ANNOUNCES STOCKHOLDER APPROVAL OF MERGER AGREEMENT WITH FRESENIUS MEDICAL CARE.‍MERGER IS EXPECTED TO BE COMPLETED IN 2018​.ABOUT 94% OF VOTE CAST AT SPECIAL MEETING OF STOCKHOLDERS VOTED IN FAVOR OF ADOPTION OF MERGER AGREEMENT WITH FRESENIUS MEDICAL CARE​.  Full Article

Photo

Prospect of tougher antitrust regulation worries deal investors

WASHINGTON The top U.S. antitrust regulator has sent a chilling message to dealmakers with his opposition to AT&T Inc buying Time Warner Inc : Companies do not have to be competitors for their merger to hurt competition, and there are no simple fixes to get such deals approved.